Bahri AKDENİZ - pvd istanbul 2016

CURRICULUM VITAE OF BAHRİ AKDENİZ
NAME and SURNAME: Assoc Prof. Bahri Akdeniz
DATE OF BIRTH: Feb 22 1969
SEX: Male
MARITAL STATUS: Married
SPOKEN LANGUAGES: Turkish, English
ACADEMIC RECORD:
Doctor of Medicine: Dokuz Eylül University, School of Medicine, İzmir, 1991
Internal Medicine: Ankara University School of Medicine Ankara 1996
Cardiologist: Dokuz Eylül University, School of Medicine, Izmir, 2000
Assistant Prof. in Cardiology: Dokuz Eylül University, School of Medicine, İzmir, 20032006
Assoc Prof in Cardiology Dokuz Eylül University, School of Medicine, İzmir 2006- 2013
Prof in Cardiology Dokuz Eylül University, School of Medicine, İzmir 2006- 2013
POSTGRADUATE CAREER
Resident and Fellow in Cardiology: Department of Cardiology, Dokuz Eylül University,
School of Medicine, Izmir, 1997-2003
Observers at stress echocardiography Cleveland Clinic Cleveland OH USA March-June 2006
Master degree of pulmonary vascular disease Bologna University Feb-Jun 2012
Member: Turkish Society of Cardiology (TSC), Pulmonary vascular project group in TSC
EXPERIENCE in CLINICAL CARDIOLOGY
-Performing transthorasic and transesophageal echocardiography since 1999
-Performing diagnostic coronary and hemodynamic procedures as primary operator.
and therapeutic coronary procedures as secondary or primary operator since 1999.
-In-hospital and outpatient care of patients with cardiac diseases.
-Attended most international meetings on cardiology.
- Interested in pulmonary hypertension for 5 years.
INTERNATIONAL MANUSCRIPTS
1. Aslan, Ö., S.Güneri, Ö. Badak, Ö. Kırımlı, Ö. Göldeli, V. Keskin, B. Akdeniz ve Ü.
Tekin, “Head – Up Tilt Testing with Low Dose Sublingual Isosorbide Dinitrate in The
Evaluation Of Unexplained Syncope: A Comparison With Isoprotrenol Infusion,” The
Canadian Journal of Cardiology, 18 (8), 853–859, (2002).
2. Kırımlı, Ö., Ş. Kalkan, .S Güneri, Y. Tunçok, B. Akdeniz, M. Özdamar ve H. Güven,
“The Effect of Captopril on Serum Digoxin Levels in Patients with Severe Congestive
Heart Failure, ”International Journal of Clinical Pharmacology and Therapeutics, 39 (7),
311–314, (2001).
3. Akdeniz B, S. Guneri, I.Z Savas, O, Aslan, N. Baris, O. Badak, O. Kirimli, O. Goldeli.
“Effects of carvedilol therapy on arrhythmia markers in patients with congestive heart
failure”. International Heart Journal, 47 (4):565–73. (2006)
4. Akdeniz, B., O. Badak, N. Barış, O. Aslan, O Kırımlı, O. Göldeli ve S. Güneri, “ Left
Atrial Appendage Flow Velocity Predicts Cardioversion Success in Atrial Fibrillation”,
Tohoku Journal of Experimental Medicine; 208: 243-50. (2006)
5. Akdeniz B, E. Yilmaz, N. Pekel, BU. Ergul. Anomalous Origin of the Right Vertebral
Artery from the Ascending Aorta in the Presence of an Aberrant Right Subclavian Artery.
International Journal of Cardiovascular Imaging; 23:39-42. (2007)
6. Baris, N., B. Akdeniz, S. Uyar, E. Ozel, O. Kirimli, O. Badak, O. Aslan ve S. Guneri,
“Are Complex Coronary Lesions More Frequent in Patients with Diabetes Mellitus ?”,
Can J Cardiol.; 22 (11) : 935–7. (2006).
7. Badak O, B. Akdeniz, O. Goldeli Five Chambered Heart: A Case Report and Brief
Review of Literature. International Journal of Cardiovascular Imaging. 22 (6): 785-9
(2006).
8. Türker, S., S. Güneri, B. Akdeniz, M. A. Özcan, N Barıs, Ö. Badak, Ö. Kırımlı ve F.
Yuksel, “ Usefulness Of Preprocedural Soluble CD40L for Predicting Restenosis After
Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease.”
American Journal of Cardiology, 97, 198-202, (2006).
9. Barış, N., T. Okan, O. Gürler, B. Akdeniz, S. Türker, I. Turna, N. Akkoç ve O. Göldeli, “
Evaluation Of Left Ventricular Diastolic Dysfunction With Conventional and Current
Doppler Techniques In Behcet’s disease,”. Clinical Rheumatology, 25, 873-876 (2006)
2
10. Maltepe, F., E. Kocaayan, B. S. Uğurlu, B. Akdeniz ve S. Güneri, “ Comparison of
Remifentanil and Fentanyl in Anesthesia for Elective Cardioversion ” Anaesthesia and
Intensive Care, 34, (3), 353-7 (2006).
11. Akdeniz, B., S. Türker, V. Öztürk, Ö. Badak, T. Okan, Ö. Aslan, Ö. Kozan, Ö. Kırımlı, D.
Aytekin, N. Barış ve S. Güneri, “Cardioversion Under The Guidance of Transesophageal
Echochardiograhy in Persistent Atrial Fibrillation: Results with Low Molecular Weight
Heparin,” International Journal of Cardiology, 98, 49–55, (2005).
12. Akdeniz, B., N. Barıs, O. Badak ve O. Aslan, “Successful Thrombolytic Therapy for
Prosthetic Mitral Valve Thrombosis with Hemodynamic Obstruction. Case report and
review the literature,” The Journal of Heart Valve Disease, 14, 687–692, (2005).
13. Guneri, S., N. Baris, D. Aytekin, B. Akdeniz, N. Pekel ve V. Bozdemir, “The
Relationship Between Angiotensin Converting Enzyme Gene Polymorphism and
Coronary Artery Disease, Stent Restenosis: Role of Angiotensin Converting Enzyme
Inhibitors in Stent Restenosis in Patients with Diabetes Mellitus,” International Heart
Journal, 46 (5), 889-897, (2005).
14. Pabuccu T, Baris N, Ozpelit E, Akdeniz B, Guneri S. The Relationship between Resistant
Hypertension and Arterial Stiffness. Clinical and Experimental Hypertension 00(00):1–6,
(2011) DOI: 10.3109 /10641963. 2011. 618203
15. Gode F, Karagoz C, Posaci C, Saatli B, Uysal D, Secil M, Akdeniz B. Alteration of
cardiovascular risk parameters in women with polycystic ovary syndrome who were
prescribed to ethinyl estradiol-cyproterone acetate. Arch Gynecol Obstet. rch Gynecol
Obstet. Oct; 2011 284 (4): 923-9. Epub 2010 Dec 8 [Epub ahead of print] DOI
10.1007/s00404-010-1790-9
16. Giugliano RP, White JA, Bode C, Armstrong PW, Montalescot G, Lewis BS, van 't Hof
A, Berdan LG, Lee KL, Strony JT, Hildemann S, Veltri E, Van de Werf F, Braunwald E,
Harrington RA, Califf RM, Newby LK; EARLY ACS Investigators. Early versus delayed,
provisional eptifibatide in acute coronary syndromes. N Engl J Med. 2009
May21;360(21):2176-90. Epub 2009 Mar 30 (yardımcı araştırıcı olarak).
17. Ozcan EE, S. Guneri, B. Akdeniz, IZ Akyildiz, O. Senaslan, N. Baris, O. Aslan, O. Badak.
“Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced
nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in
patients undergoing coronary procedures. A single-center prospective controlled trial”.
American Heart Journal, 154 (3):539-44. (2007)
18. Badak, Ö., B. Akdeniz, Ö. Aslan, Ö. Kırımlı, Ö. Göldeli ve S. Güneri. “Rare Complication
of Aortic Valve Replacement: Aorto-Right Atrial Fistula - Original Image”, Anadolu
Kardiyoloji Dergisi, 3 (4), 373, (2003).
19. Okan, T., Ö. Badak, B. Akdeniz ve S. Güneri. “Bilateral Koroner Arter Fistülü Olgu
Sunumu”, Anadolu Kadiyoloji Dergisi 3 (4),360–362 (2003).
3
20. Akdeniz B., Ö. Göldeli, N. Barış. “İzmir’in İki Farklı Kentsel Bölgesindeki Hipertansif
Hastalarda Kan Basıncı Kontrol Oranı Ve Bunu Etkileyen Epidemiyolojik Özellikler.
Editöre Mektup. Anadolu Kardiyoloji Dergisi; 5, 2, 133–4 (2005).
21. Bozdemir V, Kirimli O, Akdeniz B, Ulgenalp A, Aslan A, Kala V, Ozel E, Senarslan O,
Badak O, Bariş N, Güneri S. The association of beta-fibrinogen 455 G/A gene
polymorphism with left atrial thrombus and severe spontaneous echo contrast in atrial
fibrillation.
Anadolu
Kardiyol
Derg.
Jun;10
(3):209-15.
(2010)
doi:
10.5152/akd.2010.059.
22. Sarı İ, O. Arıcan, G. Can, B. Akdeniz, S. Akar, M. Birlik,M. Tunca, N Akkoç, S Guneri, F
Gonen Assessment of aortic stiffness and ventricular functions in familial Mediterranean
fever Anadolu Kardiyol Derg. 2008 8 (4) ; 271-278 (2008).
23. Kan basıncı düzeyi ile deri kıvrım kalınlığı ilişkisi (Editöre mektup) (Relationship
between the blood pressure level and the skinfold thickness) Anadolu Kardiyoloji
Dergisi;7 (2): 208–209 (2007)
24. Akdeniz B, Evaluation of Left ventricular Diastolic Function According to New Criteria
and determinants of those in acromegaly International Heart Journal 2012;53 (5):
25. Pabuccu T, Baris N, Ozpelit E, Akdeniz B, Guneri S. The Relationship between Resistant
Hypertension and Arterial Stiffness. Clinical and Experimental Hypertension 2011; Oct 3
DOI: 10.3109 /10641963. 2011. 618203
26. Gode F, Karagoz C, Posaci C, Saatli B, Uysal D, Secil M, Akdeniz B. Alteration of
cardiovascular risk parameters in women with polycystic ovary syndrome who were
prescribed to ethinyl estradiol-cyproterone acetate. Arch Gynecol Obstet. 2010 Dec 8.
[Epub ahead of print] DOI 10.1007/s00404-010-1790-9
27. Giugliano RP, White JA, Bode C, Armstrong PW, Montalescot G, Lewis BS, van 't Hof
A, Berdan LG, Lee KL, Strony JT, Hildemann S, Veltri E, Van de Werf F, Braunwald E,
Harrington RA, Califf RM, Newby LK; EARLY ACS Investigators. Early versus delayed,
provisional eptifibatide in acute coronary syndromes. N Engl J Med. 2009
May21;360(21):2176-90. Epub 2009 Mar 30 (yardımcı araştırıcı olarak).
28. Ozcan EE, S. Guneri, B. Akdeniz, IZ Akyildiz, O. Senaslan, N. Baris, O. Aslan, O.
Badak. “Sodium bicarbonate, N-acetylcysteine, and saline for prevention of
radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting
contrast-induced nephropathy in patients undergoing coronary procedures. A singlecenter prospective controlled trial”. American Heart Journal, 154 (3):539-44. (2007)
29. Akdeniz B, Ö. Göldeli, S. Güneri, N. Baris. Percutaneous coronary intervention in a
patient with a single right coronary artery: A case report and review of the literature.
Int J Angiol. 2007; 16 (2): 66–68.
30. Erdal C., Badak Ö., Çatalyürek H., Akdeniz B., Karabay Ö., Silistreli E., Açikel Ü Left
atrial appendage aneurysm and atrial arrhythmias Chirurgia 2007 October;20(5):2334
4
PARTICIPATION OF MULTICENTRE TRIALS
 GRIPHON Trial Phase III Prostacyclin (PGI2) Receptor agonist in pulmonary arterial
hypertension) (to be continued)
 Treatment of mild to moderate hypertension with calcium channel blockers. A multicentre
comparison of once daily amlodipine. Current Medical Research of Opinions 2003; 19:3:226237. (co-investigator)
 CLARITY (TIMI 28) trial. Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy
for Myocardial Infarction with ST-Segment Elevation Clopidogrel (N Eng J Med 2005;
355:12:1179-89) as co-investigator.
 ECLIPSE study. An evaluation to Compare Lipid Lowering effects of Rosuvastatin and
Atorvastatin in force titrated subjects: A Prospective Study of Efficacy and Tolerability (coinvestigator)
 ROCKET AF Randomized, Double-Blind Study Comparing Once Daily Oral Rivaroxaban
With Adjusted-Dose Oral Warfarin for the Prevention of Stroke in Subjects With NonValvular Atrial Fibrillation (Co-invsetigator)
 SHIFT çalışması (Systolic Heart Failure Treatment With The If Inhibitor Ivabradine Trial
) yardımcı araştırıcı Effects of ivabradine on cardiovascular events in patients with moderate
to severe chronic heart failure and left ventricular systolic dysfunction. A three-year
randomised double-blind placebo-controlled international multicentre study
 Early versus Delayed provisional eptifibatide acute coronary syndromes EARLY ACS
trial. Co-investigators. N eng J Med 2009; 360: 2176-90.
ATTENTION TO INTERNATIONAL SCIENTIFIC MEETING
09-10
November
2002 Cesme Izmir.
Clinical Research Skills
Workshop for
Investigators.
Good Clinical Practice Course
Master Kurs PhD
Alma Mater Studiorum Universita Di
Bologna İtalya / Master Pulmonary
Vascular Disease
İtaly Bologna
Cleveland Clinic Kardiyoloji – stres
eckocardiography
Cleveland /USA
2006 / 10 March 10 June
Guest investigator
2012 Şubat- Haziran
5